Why Shire plc & Royal Bank Of Scotland Group plc Could Plunge Much Further

Shire plc (LON:SHP) & Royal Bank Of Scotland Group plc (LON:RBS) carry more risk than you may think, argues this Fool.

| More on:

The content of this article was relevant at the time of publishing. Circumstances change continuously and caution should therefore be exercised when relying upon any content contained within this article.

When investing, your capital is at risk. The value of your investments can go down as well as up and you may get back less than you put in.

Read More

The content of this article is provided for information purposes only and is not intended to be, nor does it constitute, any form of personal advice. Investments in a currency other than sterling are exposed to currency exchange risk. Currency exchange rates are constantly changing, which may affect the value of the investment in sterling terms. You could lose money in sterling even if the stock price rises in the currency of origin. Stocks listed on overseas exchanges may be subject to additional dealing and exchange rate charges, and may have other tax implications, and may not provide the same, or any, regulatory protection as in the UK.

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More.

Shire (LSE: SHP) stock was a pretty straightforward investment until Tuesday 4 August, but has become a less obvious call following the British group’s hostile approach for US biotech rival Baxalta, which values the target at $30bn. 

Elsewhere, Royal Bank of Scotland (LSE: RBS) has always been an attractive restructuring story but has never been an obvious equity investment, to be honest, and now becomes even less appealing to me following the sale of a 5% stake by the UK government. 

The “Shaxalta” Risk

Baxalta has declined to engage in substantive discussions regarding the proposal, Shire said on 4 August — and this is a big headache. 

At $45.23 per Baxalta share, Shire’s offer is fair but will have to go up by 10%, 20% or more if Shire, which needs to bulk up to support its rich trading multiples, is serious about securing these assets. Its R&D pipeline is strong, but inorganic growth is essential to boost value, while becoming a more enticing takeover target itself. 

Investors have sold Shire stock since 4 August because any $30bn+ tie-up will likely bring dilution to its shareholders due to the deal’s financing mix, even though dilution risk could be mitigated by share buybacks that Shire plans to launch at a later stage: earnings per share are expected to “breakeven in year one, with accretion thereafter, supported by a share buyback program,” Shire said. 

Unsurprisingly, Shire’s share price dropped 6% on the day the proposed deal was announced, and hasn’t recovered since. Yet its stock could fall a lot more if recent news, according to which Shire will have to bid over $50 a share to buy Baxalta, is to be trusted. 

This week’s drop was because of an all-stock move, and that could mean hefty dilution if the take-out price sky-rockets, given that Shire can’t use cash because of tax-free distribution of Baxalta,” Jacob Plieth at London-based EP Vantage told me. “Well, ‘Shaxalta’ is a rather strange story,” Mr Plieth concluded. 

What Does This Mean? 

In other words, following the recent spin-off of Baxalta from Baxter, Baxalta shareholders won’t have to pay the taxman for the stock they received from the holding company, but they would have to pay a rather large tax bill if they were to receive cash — any cash — from Shire.

Hence, if a cash offer emerges then Shire’s premium for Baxalta, currently at 36%, will likely go through the roof, simply because part of that cash being offered will have to be used by Baxalta shareholders to pay their tax bill. 

The proposed transaction would be structured as an all-stock transaction to maintain the tax-free nature of Baxalta’s July 1, 2015, spinoff from Baxter. Baxalta shareholders would own approximately 37% of the combined Shire group.”

Given the peculiar nature of the deal, Shire is unlikely to lever up, which could prevent hefty dilution if the price tag goes north of $30bn, although its balance sheet could carry much more debt.

So, Shire will likely have to finance the deal issuing new stock, and lots of it. Then, Baxalta’s shareholders may even end up owning more than 37% of the combined entity, if Shire, as it seems likely, pays over the odds, one way or another. 

While the shares of Shire remain a great investment for the long term in my opinion, short-term volatility is likely to continue to push down their valuation, which would render the acquisition of Baxalta even more expensive than it currently is. 

It’s hard not to share bad feelings about the short-term outlook for RBS, too, which also came under the spotlight this week. 

Pressure Mounts On Royal Bank Of Scotland 

The UK government has decided to cut its losses on the RBS investment, selling a portion of its holding earlier this week at a price that is below the level that was required to recoup the money that it borrowed from the taxpayer in the wake of the credit crunch in 2008. 

RBS is not a bad restructuring story in the UK banking universe, but now that the government has started to sell down stock, its shares look fully priced indeed. In fact, I doubt that the benefit of future private ownership will outweigh the downwards pressure on the stock during the entire divestment process, which will take years — unless private investors smell the opportunity to sneak in. 

Consider that Lloyds, whose financials are stronger, has struggled to deliver meaningful capital appreciation for a long time, and will continue to have problems on this front at least until the UK’s government residual 15% stake isn’t sold. The Treasury now owns more than 70% of RBS’s equity, which says a lot about the risk involved in holding RBS stock over the next three or four years. Meanwhile, legal risk is still alive and well, as recent results showed. 

Should you invest, the value of your investment may rise or fall and your capital is at risk. Before investing, your individual circumstances should be assessed. Consider taking independent financial advice.

Alessandro Pasetti has no position in any shares mentioned. The Motley Fool UK has no position in any of the shares mentioned. We Fools don't all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors.

More on Investing Articles

Investing Articles

Is the Centrica share price a compelling value play?

I'm always on the lookout for investments that might be undervalued, but is the Centrica share price as cheap as…

Read more »

Investing Articles

Down 88% since its peak! Is this one of the best UK shares to buy now?

I see lots of potential shares to buy on the UK stock market right now, but I don't see explosive…

Read more »

Investing Articles

Should investors be looking at the Barclays share price?

The Barclays share price has been in rally mode lately, but is the best still to come for new investors?…

Read more »

Investing Articles

Here’s what Stocks & Shares ISA investors are buying today!

ISA investors are piling into these UK and US stocks. But which could be the best buy right now? Royston…

Read more »

Investing Articles

2 powerful passive income stocks investors should consider snapping up

Building a passive income stream via dividend-paying stocks is possible, according to our writer, who details two picks to take…

Read more »

Silhouette of a bull standing on top of a landscape with the sun setting behind it
Investing For Beginners

This UK stock has gained 42% since I bought it, but I think it’s still a bargain

Jon Smith outlines his reasons for thinking that a UK stock he owns has the potential to keep rallying for…

Read more »

Investing Articles

1 under-the-radar value stock I’m eyeing up for returns and growth

This Fool is looking for quality stocks at bargain prices and reckons this potentially overlooked value stock could be a…

Read more »

Portrait of elderly man wearing white denim shirt and glasses looking up with hand on chin. Thoughtful senior entrepreneur, studio shot against grey background.
Investing Articles

National Grid shares have plunged — but if I’d bought 2 years ago, would I be in profit?

National Grid shares are about 22% lower than in May, but that may just be a small blip for long-term…

Read more »